Brian Hoerneman, MD - Medicare Emergency Medicine in Marshfield, WI

Brian Hoerneman, MD is a medicare enrolled "Emergency Medicine" physician in Marshfield, Wisconsin. His current practice location is 1000 N Oak Ave, Marshfield, Wisconsin. You can reach out to his office (for appointments etc.) via phone at (715) 389-3893.

Brian Hoerneman is licensed to practice in Wisconsin (license number 47450) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1740385384.

Contact Information

Brian Hoerneman, MD
1000 N Oak Ave,
Marshfield, WI 54449-5777
(715) 389-3893
Not Available



Physician's Profile

Full NameBrian Hoerneman
GenderMale
SpecialityEmergency Medicine
Location1000 N Oak Ave, Marshfield, Wisconsin
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1740385384
  • Provider Enumeration Date: 09/14/2006
  • Last Update Date: 03/05/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 1355254343
  • Enrollment ID: I20041105000596

Medical Identifiers

Medical identifiers for Brian Hoerneman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1740385384NPI-NPPES
34587400MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 47450 (Wisconsin)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Brian Hoerneman allows following entities to bill medicare on his behalf.
Entity NameMarshfield Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952347981
PECOS PAC ID: 2264345206
Enrollment ID: O20031106000590

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more Medical News

› Verified 1 days ago

Entity NameMemorial Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346239373
PECOS PAC ID: 2365433224
Enrollment ID: O20040519001426

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more Medical News

› Verified 1 days ago

Entity NameFlambeau Hospital, Inc.
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1700963048
PECOS PAC ID: 9032029871
Enrollment ID: O20070828000478

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more Medical News

› Verified 1 days ago

Entity NameMemorial Hospital Inc
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1346239373
PECOS PAC ID: 2365433224
Enrollment ID: O20110526000807

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more Medical News

› Verified 1 days ago

Entity NameMchs Hospitals Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093221434
PECOS PAC ID: 5698071173
Enrollment ID: O20180208000096

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more Medical News

› Verified 1 days ago

Entity NameFlambeau Hospital, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194317966
PECOS PAC ID: 9032029871
Enrollment ID: O20210409000059

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brian Hoerneman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Brian Hoerneman, MD
1000 N Oak Ave,
Marshfield, WI 54449-5777

Ph: () -
Brian Hoerneman, MD
1000 N Oak Ave,
Marshfield, WI 54449-5777

Ph: (715) 389-3893

News Archive

EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories

The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.

Study shows protective effect of bilingualism against dementia

The conclusions of a study carried out by Víctor Costumero, as the first author, Marco Calabria and Albert Costa (died in 2018), members of the Speech Production and Bilingualism group at the Cognition and Brain Center (CBC) of the Department of Information Technology and the Communications of the UPF, together with researchers from the Universities of Jaume I, Valencia, Barcelona and Jaén; IDIBELL, Hospital La Fe (Valencia) and Grupo Médico ERESA (Valencia) show that bilingualism acts as a cognitive reserve factor against dementia.

Researchers receive $5 million NIH grant to reduce childhood obesity disparities

A research team led by the University of Minnesota Medical School has been awarded a $5 million grant from the National Institute of Health to conduct a clinical trial that hopes to identify the most effective approach to reduce racial and ethnic disparities in childhood obesity.

Same-sex couples encounter more obstacles to infertility treatment compared to opposite-sex couples

Same-sex couples encounter more obstacles to treatment for infertility than opposite-sex couples, suggests a new study that will be presented at the 110th Annual Meeting of the American Sociological Association.

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

Read more News

› Verified 1 days ago


Emergency Medicine Doctors in Marshfield, WI

Ronald Rothfusz, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1000 N Oak Ave, Marshfield, WI 54449
Phone: 715-387-7676    
Dr. Brett Sorge, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 N Oak Avenue, Marshfield, WI 54449
Phone: 715-387-5511    
David J Heegeman, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1000 N Oak Ave, Marshfield, WI 54449
Phone: 715-387-5511    
Dr. Clint L Mckee, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1000 N Oak Ave, Marshfield, WI 54449
Phone: 715-387-5511    
Dr. Lucas John Wenninger, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 N Oak Ave, Marshfield, WI 54449
Phone: 715-387-7677    
Steven H Mickel, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1000 N Oak Ave, Marshfield, WI 54449
Phone: 715-387-7676    
Dr. Corey Massey, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 N Oak Ave, Marshfield, WI 54449
Phone: 715-387-5511    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.